"This report has been commissioned by MGC Pharmaceuticals and prepared and issued by Edison, in consideration of a fee payable by MGC Pharmaceuticals. Edison Investment Research standard fees are £49,500 pafor the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for theprovision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services. "
£49,500 pa shareholders money are spent on such advertising...
- Forums
- ASX - By Stock
- RGT
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-21
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.035(12.1%) |
Mkt cap ! $13.83M |
Open | High | Low | Value | Volume |
25.5¢ | 25.5¢ | 25.5¢ | $465 | 1.824K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4408 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 8264 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4408 | 0.250 |
1 | 2200 | 0.230 |
1 | 14900 | 0.220 |
1 | 16950 | 0.200 |
1 | 5588 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 8264 | 3 |
0.300 | 136 | 2 |
0.305 | 2073 | 2 |
0.310 | 50 | 1 |
0.320 | 50 | 1 |
Last trade - 12.38pm 11/11/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online